Results 1 to 10 of about 92,053 (259)
Evaluation of Properties of Dexamethasone Eye Drops
European Pharmaceutical Journal, 2023 During the development of medicinal forms (eye drops), it is necessary to consider several parameters, so that the medicine is nonirritating to the eye and, at the same time, has the desired effect.
Matušová D. +3 more
doaj +2 more sources
Galenic validation of plasma rich in growth factors eye drops [PDF]
Farmacia Hospitalaria, 2019 Objective: Galenic evaluation of the process for obtaining and storing the platelet rich in growth factors PRGF-Endoret® eye drops. Method: To assess whether the PRGF-Endoret® eye drops process is aseptically obtained, a sterility test was carried out ...
Eduardo Anitua +4 more
doaj +2 more sources
Ocular pharmacokinetics of tivozanib eye drops in patients with neovascular age-related macular degeneration: comparison with phase 1 trials of oral tivozanib in solid tumors [PDF]
International Journal of Retina and VitreousIntravitreal anti-vascular endothelial growth factor (VEGF) therapy is the standard treatment for neovascular age-related macular degeneration (nAMD) but is invasive and burdensome for patients. To overcome these obstacles, tivozanib, a pan–VEGF receptor
Shinya Horita +5 more
doaj +2 more sources
Clinical Ophthalmology, 2022 Sruthi Srinivasan, Ravaughn Williams Alcon Research LLC, Johns Creek, GA, 30097, USACorrespondence: Sruthi Srinivasan, Alcon Research LLC, 11460 Johns Creek Parkway, Johns Creek, GA, 30097, USA, Tel +1 678 415 5315, Email sruthi.srinivasan@alcon ...
Srinivasan S, Williams R
doaj +2 more sources
Yanke XuebaoCommercial eye drops fail to fully meet the therapeutic requirements for infectious ocular diseases. When treating certain infectious ocular diseases where existing ophthalmic preparations are inadequate, extemporaneously prepared eye drops become ...
Ophthalmic Pharmacy Expert Committee of Guangdong Pharmaceutical Association
doaj +2 more sources
Clinical Ophthalmology, 2017 Semra Ozdemir,1,* Hong King Wu,1,* Eric A Finkelstein,1 Tina T Wong2 1Signature Program in Health Services and Systems Research, Duke-NUS Medical School Singapore, 2Glaucoma Department, Singapore National Eye Centre, Singapore *These authors ...
Ozdemir S +3 more
doaj +1 more source
Evaluation of the in vitro ocular toxicity of the fortified antibiotic eye drops prepared at the Hospital Pharmacy Departments [PDF]
Farmacia Hospitalaria, 2016 The use of parenteral antibiotic eye drop formulations with non-marketed compositions or concentrations, commonly called fortified antibiotic eye drops, is a common practice in Ophthalmology in the hospital setting.
Anxo Fernández-Ferreiro +8 more
doaj +1 more source
Advances in Ophthalmology Practice and Research, 2022 Background: It is possible that preservative-free eye drops can be contaminated. The aim of this study was to assess the incidence of microbial contamination of preservative-free hospital-prepared anti-infective eye drops and investigate factors that ...
Somporn Chantra +3 more
doaj +1 more source
BMJ Open Ophthalmology, 2021 Objective To investigate the short-term impact on human conjunctival goblet cell (GC) survival and mucin release of acute exposure to benzalkonium chloride (BAK) preserved and preservative-free (PF) 0.005% (w/v) latanoprost (LT) eye drops, and to compare
Steffen Heegaard +12 more
doaj +1 more source
Indian Journal of Ophthalmology, 2022 Purpose: The present study was performed to compare the optical quality of the eyes of myopic children before and after treatment with atropine eye drops of different concentrations. Methods: In the study population of 71 patients (131 eyes), 34 patients
Weiran Li, Yiting Cao, Jibo Zhou
doaj +1 more source